Status:
UNKNOWN
One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
COVID
ARDS
Eligibility:
All Genders
18+ years
Brief Summary
Many of the patients hospitalized for a severe form of SARSCoV-2 respiratory impairment require prolonged intensive care that can be complicated in the short term, In the medium and long term, physica...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients hospitalized in ICU for an ARDS table
- PCR SARSCoV-2 nasopharyngeal or positive pulmonary samples
Exclusion
Key Trial Info
Start Date :
June 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04401111
Start Date
June 16 2020
End Date
December 31 2025
Last Update
October 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06200